Evidence map›Paper›PMID 35717559›Full record

ArticleBiophysical journal2022

Computational investigation of the dynamic control of cAMP signaling by PDE4 isoform types.

Dean Paes, Sammy Hermans, Daniel van den Hove, Tim Vanmierlo, Jos Prickaerts, Aurélie Carlier

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Novel Anti-Inflammatory Approaches to COPD.International journal of chronic obstructive pulmonary disease · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Dean PaesDepartment of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, European Graduate School of Neuroscience (EURON), Maastricht University, Maastricht, the Netherlands; Department of Neuroscience, Neuro-Immune Connect and Repair lab, Biomedical Research Institute, Hasselt University, Hasselt, Belgium.
Sammy HermansDepartment of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, European Graduate School of Neuroscience (EURON), Maastricht University, Maastricht, the Netherlands.
Daniel van den HoveDepartment of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, European Graduate School of Neuroscience (EURON), Maastricht University, Maastricht, the Netherlands; Department of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany.
Tim VanmierloDepartment of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, European Graduate School of Neuroscience (EURON), Maastricht University, Maastricht, the Netherlands; Department of Neuroscience, Neuro-Immune Connect and Repair lab, Biomedical Research Institute, Hasselt University, Hasselt, Belgium.
Jos PrickaertsDepartment of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, European Graduate School of Neuroscience (EURON), Maastricht University, Maastricht, the Netherlands.
Aurélie CarlierMERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, the Netherlands. Electronic address: a.carlier@maastrichtuniversity.nl.
European Graduate School of Neuroscience · NLMaastricht University · NLHasselt University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclic adenosine monophosphate (cAMP) is a generic signaling molecule that, through precise control of its signaling dynamics, exerts distinct cellular effects. Consequently, aberrant cAMP signaling can have detrimental effects. Phosphodiesterase 4 (PDE4) enzymes profoundly control cAMP signaling and comprise different isoform types wherein enzymatic activity is modulated by differential feedback mechanisms. Because these feedback dynamics are non-linear and occur coincidentally, their effects are difficult to examine experimentally but can be well simulated computationally. Through understanding the role of PDE4 isoform types in regulating cAMP signaling, PDE4-targeted therapeutic strategies can be better specified. Here, we established a computational model to study how feedback mechanisms on different PDE4 isoform types lead to dynamic, isoform-specific control of cAMP signaling. Ordinary differential equations describing cAMP dynamics were implemented in the VirtualCell environment. Simulations indicated that long PDE4 isoforms exert the most profound control on oscillatory cAMP signaling, as opposed to the PDE4-mediated control of single cAMP input pulses. Moreover, elevating cAMP levels or decreasing PDE4 levels revealed different effects on downstream signaling. Together these results underline that cAMP signaling is distinctly regulated by different PDE4 isoform types and that this isoform specificity should be considered in both computational and experimental follow-up studies to better define PDE4 enzymes as therapeutic targets in diseases in which cAMP signaling is aberrant.

Indexed as

Cyclic AMPCyclic Nucleotide Phosphodiesterases, Type 43',5'-Cyclic-AMP PhosphodiesterasesProtein IsoformsSignal Transduction3',5'-Cyclic-AMP PhosphodiesterasesCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 4Protein Isoforms

Identifiers

PMID35717559
PMCPMC9382341
OpenAlexW4283074981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.